Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: Results of the SAfety assessment of biologic ThERapy (SABER) study
John W. Baddley, Kevin L. Winthrop, Lang Chen, Liyan Liu, Carlos G. Grijalva, Elizabeth Delzell, Timothy Beukelman, Nivedita M. Patkar, Fenglong Xie, Kenneth G. Saag, Lisa J. Herrinton, Daniel H. Solomon, James D. Lewis, Jeffrey R. Curtis
Dive into the research topics of 'Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: Results of the SAfety assessment of biologic ThERapy (SABER) study'. Together they form a unique fingerprint.